Effects of Risperidone and Galantamine Treatment on Alzheimer’s Disease Biomarker Levels in Cerebrospinal Fluid | Center for Neurodegeneration and Translational Neuroscience (CNTN)

Bloniecki V, Aarsland D, Blennow K, Cummings J, Falahati F, Winblad B

J Alzheimers Dis

January 2017

← Back to Publications